Showing results (221-230 of 781) with videos related to
Sort By:
Pageof 79
American Journal of Hypertension|April 4, 2006
A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT)William H Frishman, James W Hainer, Jennifer Sugg, et al.Cardiology in Review|January 23, 2023
Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?Joel Novograd, Jamie A Mullally, William H FrishmanCardiology in Review|July 15, 2021
Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019Tzvi Fishkin, Michael D Goldberg, William H FrishmanCardiology in Review|July 5, 2021
Cholesterol Paradigm and Beyond in Atherosclerotic Cardiovascular Disease: Cholesterol, Sterol Regulatory Element-Binding Protein, Inflammation, and Vascular Cell Mobilization in VasculopathyRuihai Zhou, George A Stouffer, William H FrishmanCardiology in Review|February 11, 2020
Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation TherapyDaniel Glicklich, Christopher T Shin, William H FrishmanCardiology in Review|January 3, 2019
Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?Mordechai Grabie, Cheng-Hung Tai, William H FrishmanCardiology in Review|October 7, 2020
Firibastat: An Oral First-in-Class Brain Aminopeptidase A Inhibitor for Systemic HypertensionJagjit Khosla, Wilbert S Aronow, William H FrishmanCardiology in Review|May 21, 2025
Kawasaki DiseaseMaryam Zeinali, William H Frishman, Wilbert S AronowCardiology in Review|May 6, 2025
Advancing Diabetes Management and Glycemic Control While Exploring CagriSema's Impact on Obesity ManagementSomar Hadid, William H Frishman, Wilbert S AronowCardiology in Review|September 9, 2025
Protein Kinase Inhibitors in Heart Failure: Mechanistic Insights and Therapeutic ProspectsRimsha Ahmad, William H Frishman, Wilbert S AronowPageof 79